Sandesh Mahatme, Senior Vice President, CFO at Sarepta Therapeutics, Inc. (SRPT), sold 30,000 shares at $50.08 ($1.5M) on 2016-10-17, disclosed to the SEC on 2016-10-19.
Open-market sale of $1.5M SRPT by Senior Vice President, CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| SRPT | SELL | 2019-02-01 | $8.5M | — | Filing → |
| SRPT | SELL | 2018-10-26 | $27.5M | — | Filing → |
| SRPT | SELL | 2017-07-21 | $2.0M | — | Filing → |